Figure 5
From: Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson’s disease
Plasma miR-133b (a), miR-221-3p (b), and miR-4454 (c) expression among patients with PD (n = 46), patients with MSA (n = 21) and healthy controls (n = 45) in cohort 3. The Kruskal–Wallis analysis with post hoc was used to evaluate differences between groups. Data are presented as the means ± SEMs. The results are indicated as ** adjust p value < 0.01, *adjust p value < 0.05, and ns: no significance. PD, Parkinson’s disease; MSA, multiple system atrophy.
